KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Non-Current Debt (2016 - 2025)

Eli Lilly's Non-Current Debt history spans 17 years, with the latest figure at $40.9 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 43.26% year-over-year to $40.9 billion; the TTM value through Dec 2025 reached $40.9 billion, up 43.26%, while the annual FY2025 figure was $40.9 billion, 43.26% up from the prior year.
  • Non-Current Debt reached $40.9 billion in Q4 2025 per LLY's latest filing, roughly flat from $40.9 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $40.9 billion in Q3 2025 to a low of $14.1 billion in Q3 2022.
  • Average Non-Current Debt over 5 years is $22.5 billion, with a median of $18.2 billion recorded in 2023.
  • Peak YoY movement for Non-Current Debt: fell 8.88% in 2022, then surged 62.05% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $15.3 billion in 2021, then fell by 3.97% to $14.7 billion in 2022, then rose by 24.31% to $18.3 billion in 2023, then skyrocketed by 55.71% to $28.5 billion in 2024, then soared by 43.26% to $40.9 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Non-Current Debt are $40.9 billion (Q4 2025), $40.9 billion (Q3 2025), and $34.2 billion (Q2 2025).